 |
Prospector
Profile
1116-06
|
| |
| Naturewell, Inc. |
NAICS |
325412 |
| 110 West C Street, Suite 1300
San Diego, CA 92101 |
Description |
Pharmaceutical Products Mfg. |
| (619) 234-0222 |
Employees |
8 |
| http://www.naturewell.com/ |
Revenue |
(mil) |
0.2850 |
| |
Income |
(mil) |
-2.3000 |
| |
Assets |
(mil) |
0.4470 |
| |
Liability |
(mil) |
6.1510 |
| |
(for the year ended 2007-06-30) |
| |
|
Category:
Default
|
| |
|
Event:
As of June 30, 2007, Naturewell, Inc. was in payment default on several secured notes, including six senior notes issued to Dutchess totaling $2,069,762, before aggregate original issue discounts of $278,299, including interest accrued thereon of $87,041. The Company has also defaulted on five senior secured notes totaling $443,143, including interest thereon of $57,915, and subordinated secured notes totaling $1,662,384, including interest thereon of $498,796. All of the defaulted notes listed have either passed their original stated maturity or are entitled to accelerated payment of principal under the default provisions of such notes. None of the holders of the defaulted notes have initiated any collection actions against the Company.
|
| |
|
Intellectual Property:
Proprietary protection for the Company's products, processes, and know-how is important to the Company's business. The Company plans to aggressively prosecute and defend its proprietary technology. The Company holds two patents and has one patent pending before the United States Patent and Trademark Office and intends to file additional patent applications to protect technology, inventions and improvements that are considered important to the development of its business. The Company also relies upon trade secrets, know-how, and technological innovation to develop and maintain its competitive position. [SEC Filing 10-KSB 10-15-07]
|
| |
|
Description:
The Company engages in the research and development of proprietary healthcare products for various conditions.
|
| |
|
Officers:
James R. Arabia (Chair, Pres. & CEO); Robert T. Malasek (CFO, Treas. & Sec.); Timothy R. Scott, PhD. (Dir.); John W. Huemoeller (Dir.)
|
| |
|
Auditor:
Chang G. Park CPA
|
| |
|
Securities:
Common Stock-Symbol NAWL.OB; OTC BB;
682,809,052 common shares outstanding as of October 5, 2007.
|
| |
| |
| |
| return to main page |
|
|
